期刊文献+

中性粒细胞与淋巴细胞比值、载脂蛋白A1对老年非瓣膜性心房颤动患者左心房血栓形成的预测价值

下载PDF
导出
摘要 目的探讨中性粒细胞与淋巴细胞比值(NLR)、载脂蛋白A1(ApoA1)对老年非瓣膜性心房颤动患者左心房血栓形成的预测价值,为今后临床治疗该疾病提供参考依据。方法选择启东市中医院2020年6月至2022年6月收治的120例老年非瓣膜性心房颤动患者作为研究对象,进行前瞻性研究。经食道心脏超声心动图检查结果显示,35例为左心房血栓患者,85例为非左心房血栓患者。比较两组一般资料,利用Logistic回归模型评估老年非瓣膜性心房颤动患者左心房血栓形成的多因素分析;利用Spearman相关性分析研究NLR、ApoA1与各指标的相关性;采用受试者工作特征(ROC)曲线评估NLR、ApoA1预测老年非瓣膜性心房颤动患者左心房血栓形成的效能。结果与非血栓组比,血栓组患者有充血性心力衰竭病史、持续性心房颤动占比及非瓣膜病房颤卒中风险(CHA2DS2-VASc)评分、左心房内径(LAD)、NLR水平均升高,左心室射血分数(LVEF)、ApoA1水平降低;多因素Logistic分析结果显示,CHA2DS2-VASc评分,以及LAD、NLR水平高,ApoA1水平低均是影响非瓣膜性心房颤动患者左心房血栓形成的独立危险因素,高LVEF水平是其保护因素;Spearman相关性分析结果显示,NLR与患者CHA2DS2-VASc评分、LAD均呈正相关,ApoA1水平与患者CHA2DS2-VASc评分、LAD均呈负相关;NLR与LVEF呈负相关,ApoA1水平与LVEF呈正相关;ROC曲线分析显示,NLR、ApoA1诊断老年非瓣膜性心房颤动患者左心房血栓的曲线下面积(AUC)分别为0.928、0.989,均具有较高的诊断价值,且ApoA1的AUC较大(均P<0.05)。结论CHA2DS2-VASc评分、LAD及NLR水平高,ApoA1水平低均是老年非瓣膜性心房颤动患者左心房血栓形成的独立危险因素,而高LVEF水平是其保护因素,且NLR、ApoA1水平与患者CHA2DS2-VASc评分、LAD及LVEF均有显著相关性,两者均对老年非瓣膜性心房颤动患者左心房血栓形成具有较高的诊断价值,且以ApoA1的诊断价值较高。
作者 施燕 陆青青
出处 《现代医学与健康研究电子杂志》 2023年第24期29-33,共5页 Modern Medicine and Health Research
  • 相关文献

参考文献13

二级参考文献69

  • 1Kirchhof P,Lip GYH,Van Gelder IC,et al.Comprehensive risk reduction in patients with atrial fibrillation:emerging diagnostic and thera-peutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Europace,2011,14:8-27.
  • 2Zhuang J,Wang Y,Tang K,et al.Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation:a systematic review and meta-analysis of observational studies.Europace,2011,14:638-645.
  • 3Ausma J,Velden HMW,Lenders MH,et al.Reverse structural and gapjunctional remodeling after prolonged atrial fibrillation in the goat.Circulation,2003,107:2051-2058.
  • 4Nattel S,Burstein B,Dobrev D.Atrial remodeling and atrial fibrillation:mechanisms and implications.Cir Arrhythm Electrophysio1,2008,1:62-73.
  • 5Kochiadakis GE,Igoumenidis NE,Hamilos ME,et al.A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.Am J Cardiol,2007,99:1721-1725.
  • 6Komatsu T,Tachibana H,Sato Y,et al.Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-Term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation.Intem Heart J,2010,51:98-104.
  • 7Roy D,Talajic M,Dorian P,et al.Amiodarone to prevent recurrence ofatrial fibrillation.Canadian Trial of Atrial Fibrillation Investigators.N Engl J Med,2000,342:913-920.
  • 8Ouyang F,Tilz R,Chun J,et al.Long-term results of catheter ablation in paroxysmal atrial fibrillation:lessons from a 5-year follow-up.Circulation,2010,122:2368-2377.
  • 9Aguilar M,Hart R. Oral anticoagulants versus anti-platelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemie attacks[l].Stroke, 2008 (39): 1399- 1400.
  • 10SPAFⅢ Writing Committee for the Stroke Prevention in Atrial Fibrilla- tion Investigatiors. Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation Ⅲ Study[J]. JAMA, 1998,279:1273-1277.

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部